Patient in vegetative state plays mental tennis
The 23-year-old patient, who suffered from injuries arising from a traffic accident, was asked to imagine playing tennis and walking around her house. The tennis request elicited activity in the supplementary motor area, while the house tour activated the parahippocampal gyrus, the posterior parietal cortex, and the lateral premotor cortex.
An unconscious and outwardly unresponsive patient apparently was capable of understanding and responding to certain commands as measured by functional MRI.
The 23-year-old patient, who suffered from injuries arising from a traffic accident, was asked to imagine playing tennis and walking around her house. The tennis request elicited activity in the supplementary motor area, while the house tour activated the parahippocampal gyrus, the posterior parietal cortex, and the lateral premotor cortex. Her brain activity matched that of 12 controls (Science 2006:313:1402).
The results represent a clear act of intention, according to Dr. Adrian Owen of Cambridge University, "which confirmed beyond any doubt that she was consciously aware of herself and her surroundings."
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
